Clearly, the United Kingdom has the edge on us this morning, because they’re getting the Animas/Dexcom “hybrid” before we are.
I received this press release in the wee hours of the morning today (Oddly enough, I was awake when it came in. Blogger zombie mode.), and I am very excited to see when this technology will be available in the US. Here are the details (and you can also read the full release). From the release:
“Animas Corporation announced today the receipt of CE Mark approval for Animas® Vibe™, the first and only continuous glucose monitoring (CGM)-enabled insulin pump system with Dexcom G4™ CGM technology. Animas® Vibe™ brings together the unique features of an Animas® insulin pump and the convenience of Dexcom CGM, which is the only sensor approved for up to seven days of wear.
As a CGM-enabled system, the Animas® Vibe™ insulin pump functions as a receiver for the Dexcom G4™ Sensor. The system delivers real-time glucose information, alerts for high and low readings, and glucose trend information, enabling patients to make more informed decisions to help control their disease*. Unlike currently available CGM-enabled pump systems, Animas® Vibe™ displays glucose trends in colour [Editor’s note: Awww. The “u” in color!] and is waterproof.**”
Two sites, one device? I’m digging it. According to the release, the Animas Vibe is offering the following features (all copy pulled from the release, including the extra u):
- “The latest technology available from Dexcom – Dexcom G4™, a tiny, round and flexible sensor with the smallest introducer needle as compared to Abbott Freestyle Navigator® and Medtronic Sof-Sensor®
- Advanced high-contrast colour pump screen technology, that displays glucose trends with coloured arrows and lines showing where and how fast glucose levels are shifting
- Dexcom sensor technology approved for up to seven days of wear, delivering more days of CGM data than those approved for a shorter duration
- Waterproof durability up to 12 feet (3.6 metres) for 24 hours for the insulin pump, with a Dexcom G4™ Transmitter that is waterproof at 8 feet (2.4 metres) for 24 hours
- Customizable alarms to indicate high and low glucose levels including a hypo-safety alarm fixed at 55 mg/dL (3.1mmol/L)
- Low basal increment (0.025 U/hr) across all available ranges (0.025 U/hr to 25.00 U/hr) for precise dosing
- Compatibility with Diasend® communications software, enabling patients to store, review and print both CGM and insulin pump data”
As both an Animas and Dexcom user, I’m very excited for when this technology becomes available in the United States. I spoke with Caroline Pavis, Director of Global Communications at Animas, about the timeline, and she had this to say: “Bringing Animas Vibe to the U.S. and Canada continues to be one of our highest priorities. Our goal is to submit Animas Vibe for approval in these countries as quickly as possible. We anticipate filing with the FDA and Health Canada in 2011.”
Come on, FDA. Let this one roll through quickly!! I can’t wait to give this a go!